These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28967552)

  • 1. Of Chemoimmunotherapy Sequences and Delayed Disease-modifying Activity in Advanced Urothelial Carcinoma: Vetus Fit Novum.
    Necchi A; Anichini A; Sonpavde G
    Eur Urol; 2018 Feb; 73(2):153-155. PubMed ID: 28967552
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoimmunotherapy in Metastatic Urothelial Carcinoma.
    Geynisman DM; Abbosh PH; Plimack ER; Zibelman M
    Eur Urol; 2018 May; 73(5):760-762. PubMed ID: 29331216
    [No Abstract]   [Full Text] [Related]  

  • 3. Facing treatment of non-urothelial bladder cancers in the immunotherapy era.
    Grilo I; Rodrigues C; Soares A; Grande E
    Crit Rev Oncol Hematol; 2020 Sep; 153():103034. PubMed ID: 32622321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bending the Curve of Advanced Urothelial Carcinoma.
    Geynisman DM; Plimack ER
    J Oncol Pract; 2017 May; 13(5):319-320. PubMed ID: 28489979
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel therapeutic targets in advanced urothelial carcinoma.
    Rouanne M; Loriot Y; Lebret T; Soria JC
    Crit Rev Oncol Hematol; 2016 Feb; 98():106-15. PubMed ID: 26589398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin-Ineligible Patients with Muscle-Invasive Localized Urothelial Carcinoma.
    Swami U; Grivas P; Agarwal N
    Oncologist; 2019 May; 24(5):580-583. PubMed ID: 30926675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urothelial cancer of the urinary bladder: can lessons learned be applied to the upper urinary tract?
    Krabbe LM; Hutchinson RC; Margulis V
    Minerva Urol Nefrol; 2016 Aug; 68(4):396-408. PubMed ID: 26990295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Advanced Small Cell Carcinoma of the Bladder: Clinical Characteristics, Treatment Patterns and Outcomes in 960 Patients and Comparison with Urothelial Carcinoma.
    Chang SS
    J Urol; 2017 Jun; 197(6):1440. PubMed ID: 28505896
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Comprehensive Genomic Profiling of 295 Cases of Clinically Advanced Urothelial Carcinoma of the Urinary Bladder Reveals a High Frequency of Clinically Relevant Genomic Alterations.
    Liedberg F
    Eur Urol; 2016 Aug; 70(2):400-1. PubMed ID: 27353966
    [No Abstract]   [Full Text] [Related]  

  • 10. Bladder cancer: uPAR expression indicates worse prognosis of urothelial carcinoma.
    Sidaway P
    Nat Rev Urol; 2015 Mar; 12(3):120. PubMed ID: 25644167
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: HER2 as a Target in Invasive Urothelial Carcinoma.
    Chang SS
    J Urol; 2016 Dec; 196(6):1637-1639. PubMed ID: 27845103
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.
    Black PC; Seiler R
    Eur Urol; 2016 Dec; 70(6):1076. PubMed ID: 27567209
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of Urothelial Bladder Cancer: Predicting the Future.
    Stadler WM
    J Oncol Pract; 2019 Aug; 15(8):429-430. PubMed ID: 31404513
    [No Abstract]   [Full Text] [Related]  

  • 14. Bladder cancer: Targeted agents reverse chemotherapy resistance in urothelial carcinoma.
    Sidaway P
    Nat Rev Urol; 2016 Sep; 13(9):494. PubMed ID: 27480945
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemoimmunotherapy in urothelial cancer: concurrent or sequential?
    Zengin ZB; Meza L; Pal SK; Grivas P
    Lancet Oncol; 2021 Jul; 22(7):894-896. PubMed ID: 34051179
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial Comment to Association between levels of urinary heavy metals and increased risk of urothelial carcinoma.
    Golabek T; Bukowczan J
    Int J Urol; 2016 Mar; 23(3):240. PubMed ID: 26833872
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunomodulatory treatment in urothelial cancer.
    Dreicer R
    Lancet Oncol; 2016 Nov; 17(11):1475-1477. PubMed ID: 27733242
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial Comment to High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer.
    Ohno Y
    Int J Urol; 2018 Mar; 25(3):238-239. PubMed ID: 29216687
    [No Abstract]   [Full Text] [Related]  

  • 19. Genomics and Therapeutic Decisions in Urothelial Malignancies.
    Vaishampayan U
    J Oncol Pract; 2019 Aug; 15(8):431-432. PubMed ID: 31404515
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Mouse and Human Urothelial Cancer Organoids: A Tool for Bladder Cancer Research.
    Atala A
    J Urol; 2019 Oct; 202(4):664. PubMed ID: 31287759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.